Security key
87650L103
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,282,321
- Total 13F shares
- 44,051,147
- Share change
- -1,686,793
- Total reported value
- $3,606,397,271
- Put/Call ratio
- 2.5%
- Price per share
- $81.88
- Number of holders
- 246
- Value change
- -$100,796,094
- Number of buys
- 128
- Number of sells
- 108
Report period
Q4 2025
Institutions
246
Top holders
10
TARS full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Tarsus Pharmaceuticals, Inc. SEC filings
Tarsus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87650L103
Recent filing periods:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
13D/G
3/4/5
|
Company · 10%+ Owner |
8.1%
from 13D/G
|
3,177,436
|
$188,835,021 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.4%
from 13D/G
|
3,779,621
|
$224,622,876 | — | 30 Sep 2025 | |
| Cowen Financial Products LLC |
13D/G
|
— |
4.9%
|
1,909,228
|
$94,926,816 | $0 | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
1,912,402
|
$113,654,091 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
13D/G
|
Company |
2.8%
from 13D/G
|
2,454,797
|
$145,888,586 | — | 30 Sep 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
7.1%
|
3,000,000
|
$178,290,000 | — | 30 Sep 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
6.3%
|
2,665,698
|
$158,422,432 | — | 30 Sep 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
6.2%
|
2,604,580
|
$154,790,191 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.4%
|
2,272,090
|
$135,030,309 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.4%
|
1,438,999
|
$85,554,237 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
3%
|
1,247,954
|
$74,165,906 | — | 30 Sep 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2.8%
|
1,167,527
|
$69,386,130 | — | 30 Sep 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.4%
|
1,031,041
|
$61,274,767 | — | 30 Sep 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
2.3%
|
985,629
|
$58,575,000 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
944,496
|
$56,140,457 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
2.2%
|
937,006
|
$55,686,267 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
936,162
|
$55,636,108 | — | 30 Sep 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2%
|
833,437
|
$49,531,000 | — | 30 Sep 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
1.5%
|
617,583
|
$36,702,958 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.4%
|
598,307
|
$35,557,385 | — | 30 Sep 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.3%
|
566,978
|
$33,695,506 | — | 30 Sep 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.3%
|
558,326
|
$33,181,314 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.3%
|
536,023
|
$31,855,847 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.2%
|
522,276
|
$31,038,863 | — | 30 Sep 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.1%
|
482,364
|
$28,666,893 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
452,857
|
$26,914,000 | — | 30 Sep 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.92%
|
389,901
|
$23,171,817 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.85%
|
358,102
|
$21,282,002 | — | 30 Sep 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.81%
|
341,496
|
$20,295,107 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.81%
|
341,012
|
$20,266,343 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.79%
|
332,912
|
$19,784,960 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.78%
|
330,680
|
$19,652,313 | — | 30 Sep 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.71%
|
300,000
|
$17,829,000 | — | 30 Sep 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.68%
|
288,344
|
$17,136,284 | — | 30 Sep 2025 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.63%
|
267,505
|
$15,897,822 | — | 30 Sep 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.63%
|
266,005
|
$15,808,677 | — | 30 Sep 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.59%
|
250,000
|
$14,857,500 | — | 30 Sep 2025 | |
| Capricorn Fund Managers Ltd |
13F
|
Company |
0.57%
|
240,020
|
$14,264,389 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.48%
|
204,300
|
$12,141,549 | — | 30 Sep 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.47%
|
197,900
|
$11,761,197 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.44%
|
184,450
|
$10,961,864 | — | 30 Sep 2025 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
0.4%
|
170,000
|
$10,103,100 | — | 30 Sep 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.35%
|
148,329
|
$8,815,244 | — | 30 Sep 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.31%
|
131,300
|
$7,803,159 | — | 30 Sep 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.3%
|
128,737
|
$7,381,779 | — | 30 Sep 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.3%
|
125,000
|
$7,428,750 | — | 30 Sep 2025 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
0.3%
|
125,000
|
$7,428,750 | — | 30 Sep 2025 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
122,341
|
$7,270,726 | — | 30 Sep 2025 | |
| Tri Locum Partners LP |
13F
|
Company |
0.28%
|
119,260
|
$7,087,622 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
118,562
|
$7,046,140 | — | 30 Sep 2025 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q4 2025
As of 31 Dec 2025,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
246 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,051,147 shares.
The largest 10 holders included
BlackRock, Inc., RTW INVESTMENTS, LP, Deep Track Capital, LP, Paradigm Biocapital Advisors LP, VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, MORGAN STANLEY, JANUS HENDERSON GROUP PLC, TANG CAPITAL MANAGEMENT LLC, and Driehaus Capital Management LLC.
This page lists
246
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
219
Q4 2025 holders
246
Holder diff
27
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.